Join the Aduhelm group to help and get support from people like you.
Aduhelm News
Biogen Is Dropping Controversial Alzheimer's Drug Aduhelm
WEDNESDAY, Jan. 31, 2024 – Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the controversial drug. Biogen...
Could a 'Brain Coach' Help Folks at Higher Risk for Alzheimer's?
TUESDAY, Nov. 28, 2023 – Personal trainers can help people increase their strength and their fitness. Could a “brain coach” be just as useful in preventing Alzheimer’s’ disease? A new study suggests ...
Eligibility Limited for Anti-β Amyloid mAbs in Seniors With MCI
FRIDAY, Aug. 18, 2023 – Older adults with cognitive impairment have limited eligibility for anti-β amyloid monoclonal antibodies when applying clinical trial criteria, according to a study published ...
Most Alzheimer's Patients May Be Ineligible for Newly Approved Drugs
THURSDAY, Aug. 17, 2023 – Two recently approved treatments offer newfound hope for patients in the early stages of Alzheimer’s disease, but most people who could benefit will likely be deemed i...
Are These Pricey New Alzheimer's Drugs Worth It?
MONDAY, July 24, 2023 – Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research. The fact that patients’ mental deterioration sl...
What Medications Are Used to Treat Alzheimer's?
WEDNESDAY, June 21, 2023 – While there is no cure for Alzheimer's, there are medications that can help ease symptoms and slow the progression of this devastating disease. Alzheimer’s disease is the m...
FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease
CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) – Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted...
Ask a question
To post your own question to this support group, sign in or create an account.